Authored By: Sarah
19 Sep 2024

Latest News: Coronavirus Test Kits Market in North America is expected to grow by a CAGR of -71.7% during 2024-2028; Trends and Forecasts to 2018

The Coronavirus Test Kits Market in North America is expected to grow at a CAGR of -71.7% to reach USD -1419 million by 2028. In the North American market, the demand for coronavirus test kits is surging due to the ongoing research and development efforts for COVID-19 vaccines. Vendors are prioritizing product visibility and quality to boost sales, utilizing their websites and awareness programs to promote test kit usage. Additionally, research organizations are innovating with multi-sample testing tool kits and emphasizing the significance of early detection. As the market evolves, vendors are introducing enhanced functionality test kits, such as multiple-use kits, to cater to the growing demand.

North America dominates the regional market because of The North American Coronavirus Test Kits market is experiencing significant growth due to the ongoing pandemic. Companies are ramping up production to meet surging demand for diagnostic tools. Key players, such as Thermo Fisher Scientific, Roche Diagnostics, and Abbott Laboratories, are leading the charge with innovative solutions and expanded capacity. Regulatory approvals and strategic collaborations are also driving market expansion.

There are various factors that drive the Coronavirus Test Kits Market in North America market which are as following: In the North American market, the integration of COVID-19 testing into routine healthcare check-ups is driving growth for coronavirus test kits. With COVID-19 transitioning from a pandemic to an endemic stage, healthcare providers are incorporating regular testing into standard medical practices. This includes screening during medical check-ups, particularly for vulnerable populations such as the elderly. The concurrent need to monitor COVID-19 alongside other respiratory illnesses, like influenza, is increasing demand for coronavirus test kits that can be used in conjunction with regular healthcare services. This approach ensures early detection and timely intervention, which is essential for managing potential outbreaks and preventing severe cases.

Be the first one to get the industry updates. Request for a sample report

Coronavirus Test Kits Market in North America Segmentation

  • End-user
    • Government
    • Non-government
  • Type
    • Rapid test kit
    • RT-PCR
    • Others
  • Geography
    • North America

The market witnesses several challenges, which are as follows The coronavirus pandemic has underscored the importance of extensive testing to mitigate its spread. However, the market for coronavirus test kits in North America faces significant challenges due to the proliferation of counterfeit products. Unscrupulous entities, including private clinics, laboratories, and intermediary distributors, are involved in the illicit trade of these fake testing kits. The distribution of counterfeit coronavirus testing kits can pose serious health risks to consumers and potentially hinder timely medical intervention for infected individuals. On March 20, 2020, US Customs and Border Protection seized counterfeit coronavirus tests at O'Hare International Airport in Chicago, highlighting the urgency of this issue.

Stay ahead of your competitors. Download the Free PDF report

Some of the key companies that have been profiled in the report include: 

  • Abbott Laboratories
  • Advaite Inc.
  • Becton Dickinson and Co.
  • Biomedomics Inc
  • bioMerieux SA
  • Cellex Inc.
  • Co Diagnostics Inc
  • Cue Health Inc.
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Laboratory Corp. of America Holdings
  • Mammoth Biosciences Inc.
  • MyBioSource Inc.
  • QIAGEN N.V.
  • QuidelOrtho Corp.
  • RayBiotech Life Inc.
  • Robert Bosch GmbH
  • Sherlock Biosciences
  • Talis Biomedical Corp
  • Thermo Fisher Scientific Inc.

Market Research Overview 

The healthcare supplies market encompasses businesses and innovations in the realm of medical consumables, including diagnostics and treatment solutions. According to Technavio, the global healthcare supplies industry is determined by the consolidated revenue generated by manufacturers of medical equipment such as syringes, drapes, gloves, and gowns. Factors propelling the expansion of this market include the increasing elderly population. By 2050, approximately one-quarter of the US population is projected to surpass the age of 60, while Europe is anticipated to reach a similar demographic milestone by 2030. This demographic shift, driven by rising life expectancy, will fuel the demand for healthcare supplies. - The Coronavirus Test Kits Market in North America is experiencing significant growth, fueled by the Integration of COVID-19 testing with routine healthcare check-ups. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Market Research Analysis

The Coronavirus Test Kits market in North America has seen a significant surge due to the ongoing COVID-19 pandemic. The market is primarily driven by the demand for Antigen Rapid Tests, which offer quick results and are essential for early detection and contact tracing. The Government of Singapore, along with other governments and healthcare providers, have been actively procuring Rapid Testing Kits to combat the rising COVID-19 cases. However, discrepancies in testing protocols and the emergence of new variants of SARS CoV 2, such as the Delta variant, have led to the need for more advanced diagnostic techniques like RT PCR tests. The market for COVID-19 Test Kits is expected to continue growing, with private funds and governments investing heavily to increase testing capacity. The market for COVID-19 Test Kits is not limited to medical devices but also includes non-medical devices, such as home testing kits. The market for COVID-19 Test Kits is diverse, with product portfolios ranging from tests for infectious diseases like COVID-19 to those for genetic disorders. Governments have granted Emergency Use Authorizations (EUAs) for several COVID-19 Test Kits, including those for Booster doses and Immunization coverage. The market for COVID-19 Test Kits is expected to remain a critical component of the global response to the pandemic, with ongoing research and development focusing on improving testing accuracy and reducing mortality rate.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.